Ares Capital - ARCC Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $21.88
  • Forecasted Upside: 8.56 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$20.15
▼ -0.4 (-1.95%)

This chart shows the closing price for ARCC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ares Capital Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARCC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARCC

Analyst Price Target is $21.88
▲ +8.56% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Ares Capital in the last 3 months. The average price target is $21.88, with a high forecast of $23.00 and a low forecast of $19.00. The average price target represents a 8.56% upside from the last price of $20.15.

This chart shows the closing price for ARCC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 8 contributing investment analysts is to buy stock in Ares Capital. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/25/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/26/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/24/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/22/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/20/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/21/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/20/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/28/2022JMP SecuritiesLower TargetMarket Outperform$24.00 ➝ $22.00Low
7/27/2022OppenheimerLower TargetOutperform$21.00Low
5/20/2022Hovde GroupLower Target$19.00Medium
4/27/2022Hovde GroupUpgradeMarket Perform ➝ OutperformMedium
4/27/2022JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$22.00Medium
4/25/2022Wells Fargo & CompanyBoost TargetOverweight$22.50 ➝ $23.00Low
3/7/2022Hovde GroupInitiated CoverageMarket Perform$22.50High
2/10/2022Raymond JamesBoost TargetOutperform$22.00 ➝ $23.00Medium
12/3/2021Janney Montgomery ScottInitiated CoverageBuy$22.00Low
11/2/2021CitigroupBoost TargetBuy$22.00 ➝ $23.00Medium
10/27/2021Raymond JamesBoost TargetOutperform$21.00 ➝ $22.00Medium
10/25/2021Wells Fargo & CompanyBoost TargetOverweight$22.00 ➝ $22.75Low
8/2/2021Raymond JamesBoost TargetOutperform$20.00 ➝ $21.00Low
7/30/2021Royal Bank of CanadaBoost TargetOutperform$21.00 ➝ $22.00Low
4/29/2021Raymond JamesBoost TargetOutperform$19.00 ➝ $20.00Low
4/29/2021WedbushBoost TargetOutperform$20.00 ➝ $21.00Low
3/17/2021JPMorgan Chase & Co.Boost TargetNeutral$18.00 ➝ $19.00Low
2/11/2021CitigroupBoost Target$17.00 ➝ $20.00Low
2/11/2021Raymond JamesBoost TargetOutperform$17.50 ➝ $19.00Low
1/8/2021Raymond JamesBoost TargetOutperform$16.00 ➝ $17.50Low
12/10/2020JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralLow
12/10/2020BarclaysDowngradeOverweight ➝ Equal Weight$16.00 ➝ $17.00Medium
10/27/2020Janney Montgomery ScottUpgradeNeutral ➝ BuyMedium
8/5/2020Raymond JamesBoost TargetOutperform$15.50 ➝ $16.00Low
8/5/2020CitigroupBoost TargetBuy$15.00 ➝ $17.00Medium
8/4/2020OppenheimerInitiated CoverageBuy$16.00Medium
6/24/2020Raymond JamesBoost TargetOutperform$14.00 ➝ $15.50Medium
6/17/2020JMP SecuritiesBoost TargetMarket Outperform$15.00 ➝ $15.50Low
5/7/2020CitigroupBoost TargetBuy$13.00 ➝ $15.00Low
5/4/2020JPMorgan Chase & Co.Lower TargetOverweight$19.50 ➝ $15.50Low
4/16/2020Raymond JamesUpgradeMarket Perform ➝ Outperform$14.00Medium
4/13/2020OppenheimerLower TargetOutperform$19.00 ➝ $16.00High
4/13/2020Bank of AmericaUpgradeNeutral ➝ Buy$16.00Low
4/7/2020CitigroupLower TargetBuy$20.00 ➝ $13.00High
4/2/2020Compass PointUpgradeNeutral ➝ BuyHigh
3/25/2020Wells Fargo & CompanyLower TargetOverweight$20.50 ➝ $15.00Low
11/12/2019Royal Bank of CanadaInitiated CoverageOutperform$20.00Low
10/22/2019Raymond JamesDowngradeOutperform ➝ Market PerformLow
8/23/2019Compass PointDowngradeBuy ➝ NeutralMedium
8/19/2019BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$19.00 ➝ $20.00Low
7/31/2019BMO Capital MarketsSet TargetHold$19.00N/A
7/31/2019Raymond JamesBoost TargetOutperform$19.00 ➝ $19.50Low
5/14/2019WedbushSet TargetBuy$20.00Low
5/1/2019National SecuritiesReiterated RatingBuy$20.00Medium
2/13/2019JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$19.00 ➝ $19.50Low
2/13/2019National SecuritiesBoost TargetBuy$19.00 ➝ $20.00Low
11/1/2018OppenheimerSet TargetBuy$18.00Low
11/1/2018National SecuritiesReiterated RatingBuy$19.00Low
8/23/2018CitigroupInitiated CoverageBuy ➝ Buy$19.00Low
8/6/2018National SecuritiesReiterated RatingBuy$19.00Low
6/4/2018JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$18.00 ➝ $18.50Low
5/15/2018National SecuritiesReiterated RatingBuy$19.00Low
5/3/2018OppenheimerSet TargetBuy$18.00Low
5/3/2018National SecuritiesReiterated RatingBuy$19.00Low
4/11/2018JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$16.50 ➝ $17.00Low
3/26/2018National SecuritiesReiterated RatingBuy$19.00Low
2/15/2018National SecuritiesReiterated RatingBuy$19.00Low
2/13/2018OppenheimerSet TargetBuy$18.00Low
12/6/2017Compass PointInitiated CoverageBuy ➝ Buy$17.50Low
11/27/2017WedbushInitiated CoverageOutperform$18.00Low
11/3/2017National SecuritiesReiterated RatingBuy$19.00N/A
11/3/2017Jefferies Financial GroupReiterated RatingBuy$19.50N/A
10/6/2017Keefe, Bruyette & WoodsSet TargetBuy$19.00N/A
9/21/2017CIBCInitiated CoverageOutperform ➝ Outperform$18.00Low
9/21/2017OppenheimerInitiated CoverageOutperform$18.00Low
9/20/2017CitigroupInitiated CoverageOutperform$18.00Low
8/25/2017BMO Capital MarketsReiterated RatingHold$15.00Low
(Data available from 8/19/2017 forward)

News Sentiment Rating

0.37 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/21/2022
  • 7 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
2/20/2022
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/22/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/21/2022
  • 5 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
5/21/2022
  • 2 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/20/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/20/2022
  • 6 very positive mentions
  • 20 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
8/19/2022

Current Sentiment

  • 6 very positive mentions
  • 20 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Ares Capital logo
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.
Read More

Today's Range

Now: $20.15
Low: $20.14
High: $20.50

50 Day Range

MA: $19.07
Low: $17.12
High: $20.70

52 Week Range

Now: $20.15
Low: $17.03
High: $23.00

Volume

1,865,807 shs

Average Volume

3,567,905 shs

Market Capitalization

$10.00 billion

P/E Ratio

9.12

Dividend Yield

8.18%

Beta

0.99

Frequently Asked Questions

What sell-side analysts currently cover shares of Ares Capital?

The following Wall Street analysts have issued research reports on Ares Capital in the last twelve months: Citigroup Inc., Hovde Group, Janney Montgomery Scott, JMP Securities, JPMorgan Chase & Co., Oppenheimer Holdings Inc., Raymond James, StockNews.com, TheStreet, and Wells Fargo & Company.
View the latest analyst ratings for ARCC.

What is the current price target for Ares Capital?

8 Wall Street analysts have set twelve-month price targets for Ares Capital in the last year. Their average twelve-month price target is $21.88, suggesting a possible upside of 8.6%. Wells Fargo & Company has the highest price target set, predicting ARCC will reach $23.00 in the next twelve months. Hovde Group has the lowest price target set, forecasting a price of $19.00 for Ares Capital in the next year.
View the latest price targets for ARCC.

What is the current consensus analyst rating for Ares Capital?

Ares Capital currently has 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ARCC will outperform the market and that investors should add to their positions of Ares Capital.
View the latest ratings for ARCC.

What other companies compete with Ares Capital?

How do I contact Ares Capital's investor relations team?

Ares Capital's physical mailing address is 245 PARK AVENUE 44TH FLOOR, NEW YORK NY, 10167. The investment management company's listed phone number is (212) 750-7300 and its investor relations email address is [email protected] The official website for Ares Capital is www.arescapitalcorp.com. Learn More about contacing Ares Capital investor relations.